KORU Medical Systems Announces Late-Stage Endocrinological Biologic Collaboration

31 July 2023 | Monday | News

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use subcutaneous infusion solutions, announced an agreement with a biopharmaceutical company to validate its FREEDOM™ Infusion System for use with the biopharma company’s drug, a novel biologic
Image Source : Public Domain

Image Source : Public Domain

Under terms of the Agreement, Koru Medical will validate the Freedom Infusion System for use with the company’s drug. The drug developer is expected to begin Phase III studies by the end of 2023 for treatment of a rare genetic disease with global prevalence of roughly 10,000 that currently has no pharmaceutical treatments.

The agreement adds to KORU Medical’s previously announced collaborations with multiple biopharmaceutical companies for Phase II and Phase III studies of treatments for neurology, immunology, pulmonology, and other diseases outside of KORU’s Medical’s core subcutaneous immunoglobulin market.

“Adding a late-stage pharmaceutical collaboration is a major milestone for our Novel Therapies business as we continue to progress our relationships to help drive greater knowledge and adoption around the benefits of subcutaneous drug delivery for patients in the home. We are excited to partner with this rare disease biopharmaceutical company to bring a therapy to an area of significant unmet need where patients have few options today,” said Linda Tharby, KORU Medical’s President and CEO. “We believe drug development companies are choosing Koru’s Freedom System because of our proven experience in delivering millions of subcutaneous home infusions each year paired with our ability to rapidly customize the Freedom System for use in their development programs and a high-confidence path to commercialization.”


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in